Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
Rhea-AI Summary
Accuray (NASDAQ: ARAY) will report second quarter fiscal 2026 results for the period ended December 31, 2025, on February 4, 2026 at 1:30 p.m. PT / 4:30 p.m. ET. Management will host a conference call; live webcast and a one-week replay will be available from the company Investor Relations website. Dial-in numbers: 1-833-316-0563 (USA) and 1-412-317-5747 (international). Replay: 1-855-669-9658 (USA) and 1-412-317-0088 (international), conference ID 8587254. Webcast replay will remain posted until Accuray announces its third quarter fiscal 2026 results.
Investor contact: Aman Patel, CFA (ICR Healthcare). Media contact: Steve Monroe, VP Financial Planning & Analysis, Accuray.
Positive
- None.
Negative
- None.
News Market Reaction – ARAY
On the day this news was published, ARAY gained 2.48%, reflecting a moderate positive market reaction. This price movement added approximately $2M to the company's valuation, bringing the market cap to $92M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ARAY was down 3.61% while peers showed mixed moves: SGHT up 0.16%, LNSR up 1.18%, BSGM up 39.91%, MASS down 0.31%, QTRX down 1.82%. With no peers in the momentum scanner, action appears stock-specific rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | Transformation plan | Neutral | -0.9% | Announced cost-focused transformation targeting improved annualized operating profitability. |
| Nov 05 | Earnings results | Neutral | +5.1% | Reported Q1 2026 results with revenue decline but reaffirmed full-year guidance. |
| Oct 31 | Inducement awards | Neutral | -0.7% | Reported CEO inducement RSUs and PSUs tied to long-term stock-price goals. |
| Oct 28 | Earnings date | Neutral | -4.5% | Announced timing and access details for upcoming Q1 2026 earnings call. |
| Oct 20 | Leadership changes | Neutral | +0.0% | Outlined CEO appointment, board changes, and preliminary Q1 financial metrics. |
Recent news shows mixed price reactions: routine or strategic updates often saw small moves, while core financial results produced larger directional reactions.
Over the past six months, Accuray has focused on transformation and leadership change. On Oct 20, 2025, it outlined leadership and board changes with preliminary Q1 2026 figures. An earnings-date announcement on Oct 28, 2025 preceded Q1 2026 results on Nov 5, 2025, where revenue declined but guidance was reaffirmed, and the stock moved about 5% higher. A December 2025 transformation plan targeted about $25 million in annualized profitability improvements and workforce reductions. Today’s release similarly schedules the upcoming Q2 2026 earnings call.
Regulatory & Risk Context
The company has an active S-3 shelf registration filed on 2025-07-28, currently shown as not yet effective, with no recorded usage to date. This provides a framework for potential future securities offerings once effective.
Market Pulse Summary
This announcement schedules Accuray’s Q2 fiscal 2026 earnings call for February 4, 2026, covering results for the quarter ended December 31, 2025. It follows recent transformation initiatives, leadership changes, and financing amendments disclosed in late 2025. Investors may focus on whether the company’s restructuring, cost actions, and updated loan terms begin to translate into improved margins and cash metrics when these results are reported.
AI-generated analysis. Not financial advice.
MADISON, Wis., Jan. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on February 4, 2026.
The conference call dial-in numbers are 1-833-316-0563 (
A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2026.
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
aman.patel@icrhealthcare.com
Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
smonroe@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2026-financial-results-on-february-4-2026-302666065.html
SOURCE Accuray Incorporated
FAQ
When will Accuray (ARAY) report its second quarter fiscal 2026 results?
What time is the Accuray (ARAY) earnings conference call on February 4, 2026?
How can investors listen to the Accuray (ARAY) Q2 FY2026 webcast?
What are the dial-in numbers for the Accuray (ARAY) Feb. 4, 2026 conference call?
Will there be a replay of the Accuray (ARAY) Q2 FY2026 call and for how long?
Who are the investor and media contacts for Accuray (ARAY) regarding the Feb. 4, 2026 results?
